The antiarrhythmic and cardiac electrophysiological effects of buprenorphine
Open Access
- 19 July 1989
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 97 (3) , 801-808
- https://doi.org/10.1111/j.1476-5381.1989.tb12019.x
Abstract
1 The effects of buprenorphine, given intravenously, on the incidence and severity of early acute coronary artery occlusion-induced arrhythmias were examined in anaesthetised rats. The electrophysiological effects of buprenorphine were also examined in sheep Purkinje fibres and rat papillary muscles, superfused in vitro with either a normal or a hypoxic, hyperkalaemic and acidotic physiological salt solution (PSS). 2 In anaesthetised rats subjected to acute coronary artery occlusion, pretreatment with buprenorphine (1 mg kg−1 i.v.) markedly reduced the incidence of ventricular extra-systoles during the initial 30 min post-occlusion period. The incidence of ventricular fibrillation (VF) was also significantly reduced from 56% to 10%. 3 At the antiarrhythmic dose (1 mg kg−1), buprenorphine also attenuated the sudden fall in systemic arterial blood pressure induced by acute coronary artery ligation. 4 In normal sheep Purkinje fibres and rat papillary muscles, buprenorphine (10−6-10−5 m) significantly reduced the action potential height and maximum rate of depolarisation of phase zero (MRD) and prolonged the duration of the action potential. 5 Superfusion of sheep Purkinje fibres and rat papillary muscles with a hypoxic, hyperkalaemic and acidotic PSS resulted in marked reductions in resting membrane potential, upstroke and duration of the action potential. 6 In the presence of the modified compared with normal PSS, buprenorphine reduced the action potential height and MRD of both sheep Purkinje fibres and rat papillary muscles to a greater extent, although its ability to prolong the action potential duration was attenuated. 7 The antiarrhythmic effects of buprenorphine observed in vivo may be explained by its direct cardiac electrophysiological effects. Buprenorphine might be useful in relieving pain and in reducing the severity of arrhythmias in the early stages of acute myocardial infarction.This publication has 19 references indexed in Scilit:
- Cardiac Electrophysiological Effects of Isoprenaline, Phenylephrine, and Noradrenaline on Normal and Mildly “Ischaemic” Sheep Purkinje FibersJournal of Cardiovascular Pharmacology, 1989
- Influence of the optical isomers (+)‐ and (−)−naloxone on beating frequency, contractile force and action potentials of guinea‐pig isolated cardiac preparationsBritish Journal of Pharmacology, 1986
- Arrhythmias associated with myocardial ischaemia and infarctionMolecular Aspects of Medicine, 1985
- SELECTIVITY OF ANTIARRHYTHMIC DRUGS AND IONIC CHANNELS: A HISTORICAL OVERVIEWAnnals of the New York Academy of Sciences, 1984
- The effects of lidocaine and quinidine on impulse propagation across the canine Purkinje-muscle junction during combined hyperkalemia, hypoxia, and acidosis.Circulation Research, 1984
- Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemiaBritish Journal of Pharmacology, 1983
- NALOXONE INHIBITS EARLY ARRHYTHMIAS RESULTING FROM ACUTE CORONARY LIGATIONBritish Journal of Pharmacology, 1982
- Physiological effects of high dose naloxone administration to normal adultsLife Sciences, 1982
- Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct sizeJournal of Pharmacological Methods, 1980
- The effect of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact porcine heart.Circulation, 1977